Article By:
Samuel Rae
Friday, January 13, 2017 4:04 PM EDT
A critical look at Blake Insmonia Therapeutics, which is trying to overcome the problems associated with standard of care sleeping pills using beta blockers as an active ingredient, against a backdrop of email promotion.
In this article: BKIT